Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Seres Therapeutics, Inc. | 12,040 | reported | 18 May 2026 | tx 90+6,676,584−424,189 |
| Sigilon Therapeutics, Inc. | 0 | reported | 11 Aug 2023 | tx 5+26,664−1,366 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 722 | — | 10b5-1 |
| 18 May 2026 | SALE | Seres Therapeutics, Inc. | 259 | 7.53 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 391 | 0.00 USD | 10b5-1deriv |
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 331 | 0.00 USD | 10b5-1deriv |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 723 | — | |
| 15 Feb 2026 | SALE | Seres Therapeutics, Inc. | 259 | 8.47 USD | |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 391 | 0.00 USD | deriv |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 333 | 0.00 USD | deriv |
| 15 Nov 2025 | SALE | Seres Therapeutics, Inc. | 217 | 17.30 USD | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 331 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 390 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 331 | 0.00 USD | deriv |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 390 | 0.00 USD | deriv |
| 18 Aug 2025 | SALE | Seres Therapeutics, Inc. | 217 | 16.65 USD | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 333 | — | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 391 | — | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 333 | 0.00 USD | deriv |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 391 | 0.00 USD | deriv |
| 16 May 2025 | SALE | Seres Therapeutics, Inc. | 220 | 7.28 USD | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 390 | — | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 331 | — | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 331 | 0.00 USD | deriv |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 390 | 0.00 USD | deriv |
| 15 Feb 2025 | EXERCISE | Seres Therapeutics, Inc. | 7,813 | — | |
| 18 Feb 2025 | SALE | Seres Therapeutics, Inc. | 12,726 | 0.81 USD |